<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004808'>Acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>)'s diagnosis is clinical and biological </plain></SENT>
<SENT sid="1" pm="."><plain>We report here 80 AML with cytology and immunophenotype features to establish correlations </plain></SENT>
<SENT sid="2" pm="."><plain>21 AML1, 23 AML2, 12 AML3, 2 AML4, 18 AML5 and 3 AML6 were diagnosed by cytology </plain></SENT>
<SENT sid="3" pm="."><plain>Only one case of AML0 was diagnosed by immunophenotype </plain></SENT>
<SENT sid="4" pm="."><plain>Myelogysplasia is present in 29.8% cases </plain></SENT>
<SENT sid="5" pm="."><plain>CD19 and CD56 expression was significantly associated to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> +t(8;21) </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, concomitant negativity of CD34 and HLA-DR was discrimininatif to AML3 diagnosis </plain></SENT>
<SENT sid="7" pm="."><plain>Prognostic value to expression some CD needs time backwards </plain></SENT>
</text></document>